Filing Details

Accession Number:
0000905718-20-000121
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-12 19:28:12
Reporting Period:
2020-02-10
Accepted Time:
2020-02-12 19:28:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1504167 Biopharmx Corp BPMX Pharmaceutical Preparations (2834) 593843182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800689 Timber Pharmaceuticals Llc 50 Tice Boulevard, Suite A26
Woodcliff Lake NJ 07677
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2020-02-10 2,255,336 $0.01 2,255,336 No 4 X Direct
Common Stock, Par Value $0.01 Per Share Disposition 2020-02-10 55,008 $0.01 2,200,328 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Footnotes
  1. On February 10, 2020, Timber Pharmaceuticals LLC (the "Reporting Person") exercised a warrant to purchase 2,255,336 shares of common stock, par value $0.01 per share (the "Warrant Shares"), of BioPharmX Corporation ("BioPharmX"). The Reporting Person paid the exercise price on a cashless basis, resulting in BioPharmX's withholding of 55,008 of the Warrant Shares to pay the exercise price and issuing the remaining 2,200,328 Warrant Shares to the Reporting Person.